nodes	percent_of_prediction	percent_of_DWPC	metapath
Carisoprodol—CYP2C19—Lapatinib—breast cancer	0.302	0.666	CbGbCtD
Carisoprodol—CYP2C19—Tamoxifen—breast cancer	0.151	0.334	CbGbCtD
Carisoprodol—Meprobamate—ABCB1—breast cancer	0.00219	1	CrCbGaD
Carisoprodol—Vomiting—Toremifene—breast cancer	0.00197	0.00378	CcSEcCtD
Carisoprodol—Headache—Fulvestrant—breast cancer	0.00196	0.00377	CcSEcCtD
Carisoprodol—Back pain—Tamoxifen—breast cancer	0.00196	0.00377	CcSEcCtD
Carisoprodol—Pancytopenia—Mitoxantrone—breast cancer	0.00195	0.00375	CcSEcCtD
Carisoprodol—Headache—Toremifene—breast cancer	0.00194	0.00372	CcSEcCtD
Carisoprodol—Pancytopenia—Gemcitabine—breast cancer	0.0019	0.00365	CcSEcCtD
Carisoprodol—Vertigo—Vinblastine—breast cancer	0.00188	0.0036	CcSEcCtD
Carisoprodol—Back pain—Goserelin—breast cancer	0.00187	0.0036	CcSEcCtD
Carisoprodol—Leukopenia—Vinblastine—breast cancer	0.00187	0.00359	CcSEcCtD
Carisoprodol—Pancytopenia—Fluorouracil—breast cancer	0.00187	0.00359	CcSEcCtD
Carisoprodol—Nausea—Fulvestrant—breast cancer	0.00186	0.00357	CcSEcCtD
Carisoprodol—Flushing—Vinorelbine—breast cancer	0.00185	0.00355	CcSEcCtD
Carisoprodol—Nausea—Toremifene—breast cancer	0.00184	0.00353	CcSEcCtD
Carisoprodol—Drowsiness—Mitoxantrone—breast cancer	0.00183	0.00352	CcSEcCtD
Carisoprodol—Blood disorder—Epirubicin—breast cancer	0.00183	0.00351	CcSEcCtD
Carisoprodol—Ataxia—Paclitaxel—breast cancer	0.00182	0.0035	CcSEcCtD
Carisoprodol—Leukopenia—Tamoxifen—breast cancer	0.00181	0.00349	CcSEcCtD
Carisoprodol—Convulsion—Vinblastine—breast cancer	0.00181	0.00347	CcSEcCtD
Carisoprodol—Dizziness—Exemestane—breast cancer	0.0018	0.00346	CcSEcCtD
Carisoprodol—Leukopenia—Melphalan—breast cancer	0.00178	0.00341	CcSEcCtD
Carisoprodol—Orthostatic hypotension—Paclitaxel—breast cancer	0.00177	0.0034	CcSEcCtD
Carisoprodol—Leukopenia—Goserelin—breast cancer	0.00173	0.00333	CcSEcCtD
Carisoprodol—Vomiting—Exemestane—breast cancer	0.00173	0.00332	CcSEcCtD
Carisoprodol—Convulsion—Melphalan—breast cancer	0.00172	0.0033	CcSEcCtD
Carisoprodol—Headache—Exemestane—breast cancer	0.0017	0.00327	CcSEcCtD
Carisoprodol—Dizziness—Ixabepilone—breast cancer	0.0017	0.00326	CcSEcCtD
Carisoprodol—Blood disorder—Doxorubicin—breast cancer	0.00169	0.00325	CcSEcCtD
Carisoprodol—Viral infection—Epirubicin—breast cancer	0.00169	0.00324	CcSEcCtD
Carisoprodol—Convulsion—Goserelin—breast cancer	0.00168	0.00322	CcSEcCtD
Carisoprodol—Back pain—Vinorelbine—breast cancer	0.00168	0.00322	CcSEcCtD
Carisoprodol—Dyspepsia—Chlorambucil—breast cancer	0.00164	0.00314	CcSEcCtD
Carisoprodol—Vomiting—Ixabepilone—breast cancer	0.00163	0.00314	CcSEcCtD
Carisoprodol—Nausea—Exemestane—breast cancer	0.00162	0.00311	CcSEcCtD
Carisoprodol—Headache—Ixabepilone—breast cancer	0.00161	0.00309	CcSEcCtD
Carisoprodol—Back pain—Thiotepa—breast cancer	0.0016	0.00308	CcSEcCtD
Carisoprodol—Dizziness—Letrozole—breast cancer	0.0016	0.00307	CcSEcCtD
Carisoprodol—Dizziness—Anastrozole—breast cancer	0.0016	0.00307	CcSEcCtD
Carisoprodol—Pancytopenia—Paclitaxel—breast cancer	0.00159	0.00305	CcSEcCtD
Carisoprodol—Tachycardia—Melphalan—breast cancer	0.00158	0.00304	CcSEcCtD
Carisoprodol—Viral infection—Doxorubicin—breast cancer	0.00156	0.003	CcSEcCtD
Carisoprodol—Vertigo—Vinorelbine—breast cancer	0.00156	0.00299	CcSEcCtD
Carisoprodol—Shock—Goserelin—breast cancer	0.00156	0.00299	CcSEcCtD
Carisoprodol—Leukopenia—Vinorelbine—breast cancer	0.00155	0.00298	CcSEcCtD
Carisoprodol—Ataxia—Docetaxel—breast cancer	0.00154	0.00297	CcSEcCtD
Carisoprodol—Tachycardia—Goserelin—breast cancer	0.00154	0.00296	CcSEcCtD
Carisoprodol—Vomiting—Anastrozole—breast cancer	0.00154	0.00295	CcSEcCtD
Carisoprodol—Vomiting—Letrozole—breast cancer	0.00154	0.00295	CcSEcCtD
Carisoprodol—Hiccups—Epirubicin—breast cancer	0.00153	0.00293	CcSEcCtD
Carisoprodol—Nausea—Ixabepilone—breast cancer	0.00153	0.00293	CcSEcCtD
Carisoprodol—Flushing—Irinotecan—breast cancer	0.00153	0.00293	CcSEcCtD
Carisoprodol—Agitation—Thiotepa—breast cancer	0.00152	0.00292	CcSEcCtD
Carisoprodol—Dizziness—Raloxifene—breast cancer	0.00152	0.00292	CcSEcCtD
Carisoprodol—Irritability—Capecitabine—breast cancer	0.00152	0.00291	CcSEcCtD
Carisoprodol—Headache—Letrozole—breast cancer	0.00151	0.00291	CcSEcCtD
Carisoprodol—Headache—Anastrozole—breast cancer	0.00151	0.00291	CcSEcCtD
Carisoprodol—Orthostatic hypotension—Docetaxel—breast cancer	0.0015	0.00288	CcSEcCtD
Carisoprodol—Insomnia—Tamoxifen—breast cancer	0.0015	0.00287	CcSEcCtD
Carisoprodol—Ataxia—Capecitabine—breast cancer	0.00149	0.00287	CcSEcCtD
Carisoprodol—Leukopenia—Thiotepa—breast cancer	0.00148	0.00285	CcSEcCtD
Carisoprodol—Vomiting—Idarubicin—breast cancer	0.00146	0.0028	CcSEcCtD
Carisoprodol—Vomiting—Raloxifene—breast cancer	0.00146	0.0028	CcSEcCtD
Carisoprodol—Dyspepsia—Tamoxifen—breast cancer	0.00146	0.0028	CcSEcCtD
Carisoprodol—Orthostatic hypotension—Capecitabine—breast cancer	0.00145	0.00279	CcSEcCtD
Carisoprodol—Headache—Raloxifene—breast cancer	0.00144	0.00276	CcSEcCtD
Carisoprodol—Headache—Idarubicin—breast cancer	0.00144	0.00276	CcSEcCtD
Carisoprodol—Nausea—Anastrozole—breast cancer	0.00144	0.00276	CcSEcCtD
Carisoprodol—Nausea—Letrozole—breast cancer	0.00144	0.00276	CcSEcCtD
Carisoprodol—Convulsion—Thiotepa—breast cancer	0.00144	0.00276	CcSEcCtD
Carisoprodol—Insomnia—Goserelin—breast cancer	0.00143	0.00275	CcSEcCtD
Carisoprodol—Dyspepsia—Melphalan—breast cancer	0.00143	0.00274	CcSEcCtD
Carisoprodol—Hiccups—Doxorubicin—breast cancer	0.00141	0.00271	CcSEcCtD
Carisoprodol—Somnolence—Goserelin—breast cancer	0.00141	0.0027	CcSEcCtD
Carisoprodol—Dyspepsia—Goserelin—breast cancer	0.00139	0.00267	CcSEcCtD
Carisoprodol—Back pain—Irinotecan—breast cancer	0.00138	0.00266	CcSEcCtD
Carisoprodol—Back pain—Mitoxantrone—breast cancer	0.00138	0.00266	CcSEcCtD
Carisoprodol—Tachycardia—Vinorelbine—breast cancer	0.00138	0.00265	CcSEcCtD
Carisoprodol—Nausea—Idarubicin—breast cancer	0.00136	0.00262	CcSEcCtD
Carisoprodol—Nausea—Raloxifene—breast cancer	0.00136	0.00262	CcSEcCtD
Carisoprodol—Back pain—Gemcitabine—breast cancer	0.00135	0.00259	CcSEcCtD
Carisoprodol—Pancytopenia—Docetaxel—breast cancer	0.00135	0.00259	CcSEcCtD
Carisoprodol—Tachycardia—Thiotepa—breast cancer	0.00132	0.00253	CcSEcCtD
Carisoprodol—Pancytopenia—Capecitabine—breast cancer	0.0013	0.00251	CcSEcCtD
Carisoprodol—Vertigo—Irinotecan—breast cancer	0.00129	0.00247	CcSEcCtD
Carisoprodol—Syncope—Irinotecan—breast cancer	0.00128	0.00246	CcSEcCtD
Carisoprodol—Leukopenia—Mitoxantrone—breast cancer	0.00128	0.00246	CcSEcCtD
Carisoprodol—Leukopenia—Irinotecan—breast cancer	0.00128	0.00246	CcSEcCtD
Carisoprodol—Loss of consciousness—Irinotecan—breast cancer	0.00126	0.00242	CcSEcCtD
Carisoprodol—Leukopenia—Gemcitabine—breast cancer	0.00125	0.0024	CcSEcCtD
Carisoprodol—Flushing—Paclitaxel—breast cancer	0.00124	0.00239	CcSEcCtD
Carisoprodol—Convulsion—Mitoxantrone—breast cancer	0.00124	0.00238	CcSEcCtD
Carisoprodol—Leukopenia—Fluorouracil—breast cancer	0.00123	0.00236	CcSEcCtD
Carisoprodol—Somnolence—Thiotepa—breast cancer	0.0012	0.00231	CcSEcCtD
Carisoprodol—Dyspepsia—Thiotepa—breast cancer	0.00119	0.00229	CcSEcCtD
Carisoprodol—Convulsion—Fluorouracil—breast cancer	0.00119	0.00228	CcSEcCtD
Carisoprodol—Vomiting—Chlorambucil—breast cancer	0.00118	0.00227	CcSEcCtD
Carisoprodol—Shock—Mitoxantrone—breast cancer	0.00115	0.00221	CcSEcCtD
Carisoprodol—Shock—Irinotecan—breast cancer	0.00115	0.00221	CcSEcCtD
Carisoprodol—Tachycardia—Mitoxantrone—breast cancer	0.00114	0.00219	CcSEcCtD
Carisoprodol—CYP2C19—Melatonin metabolism and effects—PER3—breast cancer	0.00113	0.0482	CbGpPWpGaD
Carisoprodol—Irritability—Methotrexate—breast cancer	0.00113	0.00217	CcSEcCtD
Carisoprodol—Back pain—Paclitaxel—breast cancer	0.00113	0.00217	CcSEcCtD
Carisoprodol—Dizziness—Vinblastine—breast cancer	0.00113	0.00216	CcSEcCtD
Carisoprodol—Ataxia—Methotrexate—breast cancer	0.00111	0.00214	CcSEcCtD
Carisoprodol—Nausea—Chlorambucil—breast cancer	0.0011	0.00212	CcSEcCtD
Carisoprodol—Dizziness—Tamoxifen—breast cancer	0.00109	0.0021	CcSEcCtD
Carisoprodol—Tremor—Paclitaxel—breast cancer	0.00109	0.0021	CcSEcCtD
Carisoprodol—Tachycardia—Fluorouracil—breast cancer	0.00109	0.0021	CcSEcCtD
Carisoprodol—Vomiting—Vinblastine—breast cancer	0.00108	0.00208	CcSEcCtD
Carisoprodol—Agitation—Paclitaxel—breast cancer	0.00107	0.00206	CcSEcCtD
Carisoprodol—Headache—Vinblastine—breast cancer	0.00107	0.00205	CcSEcCtD
Carisoprodol—Insomnia—Irinotecan—breast cancer	0.00106	0.00203	CcSEcCtD
Carisoprodol—Flushing—Docetaxel—breast cancer	0.00105	0.00203	CcSEcCtD
Carisoprodol—Vomiting—Tamoxifen—breast cancer	0.00105	0.00202	CcSEcCtD
Carisoprodol—Vertigo—Paclitaxel—breast cancer	0.00105	0.00201	CcSEcCtD
Carisoprodol—Syncope—Paclitaxel—breast cancer	0.00105	0.00201	CcSEcCtD
Carisoprodol—Dizziness—Goserelin—breast cancer	0.00105	0.00201	CcSEcCtD
Carisoprodol—Leukopenia—Paclitaxel—breast cancer	0.00104	0.00201	CcSEcCtD
Carisoprodol—Ataxia—Epirubicin—breast cancer	0.00104	0.002	CcSEcCtD
Carisoprodol—Somnolence—Irinotecan—breast cancer	0.00104	0.00199	CcSEcCtD
Carisoprodol—Somnolence—Mitoxantrone—breast cancer	0.00104	0.00199	CcSEcCtD
Carisoprodol—Headache—Tamoxifen—breast cancer	0.00104	0.00199	CcSEcCtD
Carisoprodol—Vomiting—Melphalan—breast cancer	0.00103	0.00198	CcSEcCtD
Carisoprodol—Insomnia—Gemcitabine—breast cancer	0.00103	0.00198	CcSEcCtD
Carisoprodol—Dyspepsia—Mitoxantrone—breast cancer	0.00103	0.00197	CcSEcCtD
Carisoprodol—Dyspepsia—Irinotecan—breast cancer	0.00103	0.00197	CcSEcCtD
Carisoprodol—Loss of consciousness—Paclitaxel—breast cancer	0.00103	0.00197	CcSEcCtD
Carisoprodol—Flushing—Capecitabine—breast cancer	0.00102	0.00196	CcSEcCtD
Carisoprodol—Nausea—Vinblastine—breast cancer	0.00101	0.00194	CcSEcCtD
Carisoprodol—Orthostatic hypotension—Epirubicin—breast cancer	0.00101	0.00194	CcSEcCtD
Carisoprodol—Insomnia—Fluorouracil—breast cancer	0.00101	0.00194	CcSEcCtD
Carisoprodol—Somnolence—Gemcitabine—breast cancer	0.00101	0.00194	CcSEcCtD
Carisoprodol—Convulsion—Paclitaxel—breast cancer	0.00101	0.00194	CcSEcCtD
Carisoprodol—Vomiting—Goserelin—breast cancer	0.001	0.00193	CcSEcCtD
Carisoprodol—Somnolence—Fluorouracil—breast cancer	0.000994	0.00191	CcSEcCtD
Carisoprodol—Headache—Goserelin—breast cancer	0.00099	0.0019	CcSEcCtD
Carisoprodol—Dyspepsia—Fluorouracil—breast cancer	0.000984	0.00189	CcSEcCtD
Carisoprodol—Nausea—Tamoxifen—breast cancer	0.000983	0.00189	CcSEcCtD
Carisoprodol—Pancytopenia—Methotrexate—breast cancer	0.000971	0.00187	CcSEcCtD
Carisoprodol—Ataxia—Doxorubicin—breast cancer	0.000964	0.00185	CcSEcCtD
Carisoprodol—Nausea—Melphalan—breast cancer	0.000962	0.00185	CcSEcCtD
Carisoprodol—Back pain—Docetaxel—breast cancer	0.000957	0.00184	CcSEcCtD
Carisoprodol—Nausea—Goserelin—breast cancer	0.000939	0.0018	CcSEcCtD
Carisoprodol—Shock—Paclitaxel—breast cancer	0.000937	0.0018	CcSEcCtD
Carisoprodol—Dizziness—Vinorelbine—breast cancer	0.000936	0.0018	CcSEcCtD
Carisoprodol—Orthostatic hypotension—Doxorubicin—breast cancer	0.000936	0.0018	CcSEcCtD
Carisoprodol—Tachycardia—Paclitaxel—breast cancer	0.000929	0.00178	CcSEcCtD
Carisoprodol—Back pain—Capecitabine—breast cancer	0.000926	0.00178	CcSEcCtD
Carisoprodol—Drowsiness—Methotrexate—breast cancer	0.000912	0.00175	CcSEcCtD
Carisoprodol—Pancytopenia—Epirubicin—breast cancer	0.000909	0.00175	CcSEcCtD
Carisoprodol—Vomiting—Vinorelbine—breast cancer	0.0009	0.00173	CcSEcCtD
Carisoprodol—Tremor—Capecitabine—breast cancer	0.000897	0.00172	CcSEcCtD
Carisoprodol—Dizziness—Thiotepa—breast cancer	0.000894	0.00172	CcSEcCtD
Carisoprodol—Headache—Vinorelbine—breast cancer	0.000887	0.0017	CcSEcCtD
Carisoprodol—Syncope—Docetaxel—breast cancer	0.000887	0.0017	CcSEcCtD
Carisoprodol—Leukopenia—Docetaxel—breast cancer	0.000885	0.0017	CcSEcCtD
Carisoprodol—Loss of consciousness—Docetaxel—breast cancer	0.000869	0.00167	CcSEcCtD
Carisoprodol—Insomnia—Paclitaxel—breast cancer	0.000861	0.00165	CcSEcCtD
Carisoprodol—Vertigo—Capecitabine—breast cancer	0.00086	0.00165	CcSEcCtD
Carisoprodol—Vomiting—Thiotepa—breast cancer	0.00086	0.00165	CcSEcCtD
Carisoprodol—Syncope—Capecitabine—breast cancer	0.000859	0.00165	CcSEcCtD
Carisoprodol—Leukopenia—Capecitabine—breast cancer	0.000857	0.00165	CcSEcCtD
Carisoprodol—Convulsion—Docetaxel—breast cancer	0.000857	0.00165	CcSEcCtD
Carisoprodol—Drowsiness—Epirubicin—breast cancer	0.000854	0.00164	CcSEcCtD
Carisoprodol—Headache—Thiotepa—breast cancer	0.000847	0.00163	CcSEcCtD
Carisoprodol—Somnolence—Paclitaxel—breast cancer	0.000846	0.00163	CcSEcCtD
Carisoprodol—Loss of consciousness—Capecitabine—breast cancer	0.000842	0.00162	CcSEcCtD
Carisoprodol—Pancytopenia—Doxorubicin—breast cancer	0.000841	0.00162	CcSEcCtD
Carisoprodol—Nausea—Vinorelbine—breast cancer	0.000841	0.00162	CcSEcCtD
Carisoprodol—Dyspepsia—Paclitaxel—breast cancer	0.000838	0.00161	CcSEcCtD
Carisoprodol—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—breast cancer	0.000816	0.0347	CbGpPWpGaD
Carisoprodol—Nausea—Thiotepa—breast cancer	0.000803	0.00154	CcSEcCtD
Carisoprodol—Shock—Docetaxel—breast cancer	0.000794	0.00153	CcSEcCtD
Carisoprodol—Drowsiness—Doxorubicin—breast cancer	0.00079	0.00152	CcSEcCtD
Carisoprodol—Tachycardia—Docetaxel—breast cancer	0.000788	0.00151	CcSEcCtD
Carisoprodol—Dizziness—Irinotecan—breast cancer	0.000772	0.00148	CcSEcCtD
Carisoprodol—Shock—Capecitabine—breast cancer	0.000769	0.00148	CcSEcCtD
Carisoprodol—Tachycardia—Capecitabine—breast cancer	0.000763	0.00146	CcSEcCtD
Carisoprodol—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—breast cancer	0.000742	0.0315	CbGpPWpGaD
Carisoprodol—Vomiting—Mitoxantrone—breast cancer	0.000742	0.00143	CcSEcCtD
Carisoprodol—Vomiting—Irinotecan—breast cancer	0.000742	0.00143	CcSEcCtD
Carisoprodol—Dizziness—Fluorouracil—breast cancer	0.000739	0.00142	CcSEcCtD
Carisoprodol—Headache—Mitoxantrone—breast cancer	0.000731	0.0014	CcSEcCtD
Carisoprodol—Headache—Irinotecan—breast cancer	0.000731	0.0014	CcSEcCtD
Carisoprodol—Insomnia—Docetaxel—breast cancer	0.00073	0.0014	CcSEcCtD
Carisoprodol—CYP2C19—CYP2E1 reactions—CYP2D6—breast cancer	0.000729	0.031	CbGpPWpGaD
Carisoprodol—Vomiting—Gemcitabine—breast cancer	0.000723	0.00139	CcSEcCtD
Carisoprodol—Somnolence—Docetaxel—breast cancer	0.000717	0.00138	CcSEcCtD
Carisoprodol—Headache—Gemcitabine—breast cancer	0.000712	0.00137	CcSEcCtD
Carisoprodol—Flushing—Epirubicin—breast cancer	0.000711	0.00137	CcSEcCtD
Carisoprodol—Vomiting—Fluorouracil—breast cancer	0.000711	0.00137	CcSEcCtD
Carisoprodol—Dyspepsia—Docetaxel—breast cancer	0.00071	0.00136	CcSEcCtD
Carisoprodol—Insomnia—Capecitabine—breast cancer	0.000707	0.00136	CcSEcCtD
Carisoprodol—Headache—Fluorouracil—breast cancer	0.000701	0.00135	CcSEcCtD
Carisoprodol—Nausea—Irinotecan—breast cancer	0.000693	0.00133	CcSEcCtD
Carisoprodol—Nausea—Mitoxantrone—breast cancer	0.000693	0.00133	CcSEcCtD
Carisoprodol—Back pain—Methotrexate—breast cancer	0.000689	0.00132	CcSEcCtD
Carisoprodol—Dyspepsia—Capecitabine—breast cancer	0.000688	0.00132	CcSEcCtD
Carisoprodol—Nausea—Gemcitabine—breast cancer	0.000676	0.0013	CcSEcCtD
Carisoprodol—Nausea—Fluorouracil—breast cancer	0.000664	0.00128	CcSEcCtD
Carisoprodol—Flushing—Doxorubicin—breast cancer	0.000658	0.00126	CcSEcCtD
Carisoprodol—Back pain—Epirubicin—breast cancer	0.000645	0.00124	CcSEcCtD
Carisoprodol—Vertigo—Methotrexate—breast cancer	0.00064	0.00123	CcSEcCtD
Carisoprodol—Leukopenia—Methotrexate—breast cancer	0.000638	0.00123	CcSEcCtD
Carisoprodol—CYP2C19—Tamoxifen metabolism—SULT1A1—breast cancer	0.000632	0.0268	CbGpPWpGaD
Carisoprodol—Dizziness—Paclitaxel—breast cancer	0.00063	0.00121	CcSEcCtD
Carisoprodol—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1A1—breast cancer	0.000618	0.0263	CbGpPWpGaD
Carisoprodol—Convulsion—Methotrexate—breast cancer	0.000618	0.00119	CcSEcCtD
Carisoprodol—Agitation—Epirubicin—breast cancer	0.000613	0.00118	CcSEcCtD
Carisoprodol—Vomiting—Paclitaxel—breast cancer	0.000605	0.00116	CcSEcCtD
Carisoprodol—Vertigo—Epirubicin—breast cancer	0.000599	0.00115	CcSEcCtD
Carisoprodol—Syncope—Epirubicin—breast cancer	0.000598	0.00115	CcSEcCtD
Carisoprodol—Leukopenia—Epirubicin—breast cancer	0.000597	0.00115	CcSEcCtD
Carisoprodol—Back pain—Doxorubicin—breast cancer	0.000597	0.00115	CcSEcCtD
Carisoprodol—Headache—Paclitaxel—breast cancer	0.000597	0.00115	CcSEcCtD
Carisoprodol—Loss of consciousness—Epirubicin—breast cancer	0.000586	0.00113	CcSEcCtD
Carisoprodol—Convulsion—Epirubicin—breast cancer	0.000578	0.00111	CcSEcCtD
Carisoprodol—Agitation—Doxorubicin—breast cancer	0.000567	0.00109	CcSEcCtD
Carisoprodol—Nausea—Paclitaxel—breast cancer	0.000566	0.00109	CcSEcCtD
Carisoprodol—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1A1—breast cancer	0.000563	0.0239	CbGpPWpGaD
Carisoprodol—Vertigo—Doxorubicin—breast cancer	0.000554	0.00107	CcSEcCtD
Carisoprodol—Syncope—Doxorubicin—breast cancer	0.000553	0.00106	CcSEcCtD
Carisoprodol—Leukopenia—Doxorubicin—breast cancer	0.000552	0.00106	CcSEcCtD
Carisoprodol—Loss of consciousness—Doxorubicin—breast cancer	0.000542	0.00104	CcSEcCtD
Carisoprodol—Shock—Epirubicin—breast cancer	0.000536	0.00103	CcSEcCtD
Carisoprodol—Convulsion—Doxorubicin—breast cancer	0.000535	0.00103	CcSEcCtD
Carisoprodol—Dizziness—Docetaxel—breast cancer	0.000534	0.00103	CcSEcCtD
Carisoprodol—Tachycardia—Epirubicin—breast cancer	0.000531	0.00102	CcSEcCtD
Carisoprodol—Insomnia—Methotrexate—breast cancer	0.000526	0.00101	CcSEcCtD
Carisoprodol—Somnolence—Methotrexate—breast cancer	0.000517	0.000993	CcSEcCtD
Carisoprodol—Dizziness—Capecitabine—breast cancer	0.000517	0.000992	CcSEcCtD
Carisoprodol—Vomiting—Docetaxel—breast cancer	0.000513	0.000986	CcSEcCtD
Carisoprodol—Dyspepsia—Methotrexate—breast cancer	0.000512	0.000984	CcSEcCtD
Carisoprodol—Headache—Docetaxel—breast cancer	0.000506	0.000971	CcSEcCtD
Carisoprodol—Vomiting—Capecitabine—breast cancer	0.000497	0.000954	CcSEcCtD
Carisoprodol—Shock—Doxorubicin—breast cancer	0.000496	0.000952	CcSEcCtD
Carisoprodol—Insomnia—Epirubicin—breast cancer	0.000492	0.000946	CcSEcCtD
Carisoprodol—Tachycardia—Doxorubicin—breast cancer	0.000492	0.000944	CcSEcCtD
Carisoprodol—Headache—Capecitabine—breast cancer	0.00049	0.00094	CcSEcCtD
Carisoprodol—Somnolence—Epirubicin—breast cancer	0.000484	0.00093	CcSEcCtD
Carisoprodol—Nausea—Docetaxel—breast cancer	0.000479	0.000921	CcSEcCtD
Carisoprodol—Dyspepsia—Epirubicin—breast cancer	0.000479	0.00092	CcSEcCtD
Carisoprodol—Nausea—Capecitabine—breast cancer	0.000464	0.000892	CcSEcCtD
Carisoprodol—CYP2C19—Constitutive Androstane Receptor Pathway—GSTA2—breast cancer	0.000457	0.0194	CbGpPWpGaD
Carisoprodol—Insomnia—Doxorubicin—breast cancer	0.000456	0.000875	CcSEcCtD
Carisoprodol—CYP2C19—Xenobiotics—CYP2D6—breast cancer	0.000452	0.0192	CbGpPWpGaD
Carisoprodol—CYP2C19—Constitutive Androstane Receptor Pathway—SULT1A1—breast cancer	0.000451	0.0192	CbGpPWpGaD
Carisoprodol—Somnolence—Doxorubicin—breast cancer	0.000448	0.00086	CcSEcCtD
Carisoprodol—Dyspepsia—Doxorubicin—breast cancer	0.000443	0.000852	CcSEcCtD
Carisoprodol—CYP2C19—Tamoxifen metabolism—CYP2D6—breast cancer	0.000435	0.0185	CbGpPWpGaD
Carisoprodol—CYP2C19—Xenobiotics—CYP3A4—breast cancer	0.000399	0.0169	CbGpPWpGaD
Carisoprodol—Dizziness—Methotrexate—breast cancer	0.000385	0.000739	CcSEcCtD
Carisoprodol—CYP2C19—Tamoxifen metabolism—CYP3A4—breast cancer	0.000383	0.0163	CbGpPWpGaD
Carisoprodol—CYP2C19—Tamoxifen metabolism—CYP1B1—breast cancer	0.000377	0.016	CbGpPWpGaD
Carisoprodol—Vomiting—Methotrexate—breast cancer	0.00037	0.00071	CcSEcCtD
Carisoprodol—CYP2C19—Melatonin metabolism and effects—ACHE—breast cancer	0.000365	0.0155	CbGpPWpGaD
Carisoprodol—Headache—Methotrexate—breast cancer	0.000364	0.0007	CcSEcCtD
Carisoprodol—Dizziness—Epirubicin—breast cancer	0.00036	0.000691	CcSEcCtD
Carisoprodol—CYP2C19—Arachidonic acid metabolism—ABCC1—breast cancer	0.000358	0.0152	CbGpPWpGaD
Carisoprodol—Vomiting—Epirubicin—breast cancer	0.000346	0.000665	CcSEcCtD
Carisoprodol—Nausea—Methotrexate—breast cancer	0.000346	0.000664	CcSEcCtD
Carisoprodol—Headache—Epirubicin—breast cancer	0.000341	0.000655	CcSEcCtD
Carisoprodol—CYP2C19—Melatonin metabolism and effects—CYP2D6—breast cancer	0.000336	0.0143	CbGpPWpGaD
Carisoprodol—Dizziness—Doxorubicin—breast cancer	0.000333	0.00064	CcSEcCtD
Carisoprodol—Nausea—Epirubicin—breast cancer	0.000323	0.000621	CcSEcCtD
Carisoprodol—Vomiting—Doxorubicin—breast cancer	0.00032	0.000615	CcSEcCtD
Carisoprodol—CYP2C19—Arachidonic acid metabolism—GPX2—breast cancer	0.00032	0.0136	CbGpPWpGaD
Carisoprodol—CYP2C19—Arachidonic acid metabolism—GPX4—breast cancer	0.000316	0.0134	CbGpPWpGaD
Carisoprodol—Headache—Doxorubicin—breast cancer	0.000316	0.000606	CcSEcCtD
Carisoprodol—CYP2C19—Constitutive Androstane Receptor Pathway—NCOA2—breast cancer	0.000305	0.0129	CbGpPWpGaD
Carisoprodol—Nausea—Doxorubicin—breast cancer	0.000299	0.000575	CcSEcCtD
Carisoprodol—CYP2C19—Xenobiotics—CYP1A1—breast cancer	0.000297	0.0126	CbGpPWpGaD
Carisoprodol—CYP2C19—Melatonin metabolism and effects—CYP1B1—breast cancer	0.000291	0.0124	CbGpPWpGaD
Carisoprodol—CYP2C19—Tamoxifen metabolism—CYP1A1—breast cancer	0.000286	0.0121	CbGpPWpGaD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—ALDH1A1—breast cancer	0.000282	0.012	CbGpPWpGaD
Carisoprodol—CYP2C19—Constitutive Androstane Receptor Pathway—CYP3A4—breast cancer	0.000274	0.0116	CbGpPWpGaD
Carisoprodol—CYP2C19—Constitutive Androstane Receptor Pathway—HSP90AA1—breast cancer	0.000264	0.0112	CbGpPWpGaD
Carisoprodol—CYP2C19—Constitutive Androstane Receptor Pathway—NCOA1—breast cancer	0.000257	0.0109	CbGpPWpGaD
Carisoprodol—CYP2C19—Arachidonic acid metabolism—HPGDS—breast cancer	0.000244	0.0104	CbGpPWpGaD
Carisoprodol—CYP2C19—Constitutive Androstane Receptor Pathway—ABCB1—breast cancer	0.000222	0.00942	CbGpPWpGaD
Carisoprodol—CYP2C19—Arachidonic acid metabolism—PTGS1—breast cancer	0.000221	0.00941	CbGpPWpGaD
Carisoprodol—CYP2C19—Melatonin metabolism and effects—CYP1A1—breast cancer	0.000221	0.00938	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—CHST9—breast cancer	0.000215	0.00915	CbGpPWpGaD
Carisoprodol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP17A1—breast cancer	0.000193	0.00822	CbGpPWpGaD
Carisoprodol—CYP2C19—Oxidation by Cytochrome P450—CYP17A1—breast cancer	0.000191	0.00811	CbGpPWpGaD
Carisoprodol—CYP2C19—Arachidonic acid metabolism—CYP1B1—breast cancer	0.000188	0.008	CbGpPWpGaD
Carisoprodol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2D6—breast cancer	0.000188	0.00798	CbGpPWpGaD
Carisoprodol—CYP2C19—Oxidation by Cytochrome P450—CYP2D6—breast cancer	0.000185	0.00787	CbGpPWpGaD
Carisoprodol—CYP2C19—Cytochrome P450 - arranged by substrate type—NCOA2—breast cancer	0.000184	0.00783	CbGpPWpGaD
Carisoprodol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP3A4—breast cancer	0.000166	0.00703	CbGpPWpGaD
Carisoprodol—CYP2C19—Oxidation by Cytochrome P450—CYP3A4—breast cancer	0.000163	0.00694	CbGpPWpGaD
Carisoprodol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—breast cancer	0.000163	0.00692	CbGpPWpGaD
Carisoprodol—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—breast cancer	0.000161	0.00682	CbGpPWpGaD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—CYP17A1—breast cancer	0.000157	0.00666	CbGpPWpGaD
Carisoprodol—CYP2C19—Cytochrome P450 - arranged by substrate type—NCOA1—breast cancer	0.000155	0.0066	CbGpPWpGaD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—PTGS1—breast cancer	0.000155	0.00659	CbGpPWpGaD
Carisoprodol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—breast cancer	0.000153	0.0065	CbGpPWpGaD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—CYP2D6—breast cancer	0.000152	0.00647	CbGpPWpGaD
Carisoprodol—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—breast cancer	0.000151	0.00642	CbGpPWpGaD
Carisoprodol—CYP2C19—Arachidonic acid metabolism—PLA2G4A—breast cancer	0.000151	0.0064	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—ALDH1A1—breast cancer	0.00015	0.00636	CbGpPWpGaD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—NCOA2—breast cancer	0.000149	0.00635	CbGpPWpGaD
Carisoprodol—CYP2C19—Arachidonic acid metabolism—GPX1—breast cancer	0.000144	0.00613	CbGpPWpGaD
Carisoprodol—CYP2C19—Arachidonic acid metabolism—CYP1A1—breast cancer	0.000143	0.00606	CbGpPWpGaD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—CYP3A4—breast cancer	0.000134	0.0057	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—GSTA3—breast cancer	0.000133	0.00567	CbGpPWpGaD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—breast cancer	0.000132	0.00561	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—GSTA3—breast cancer	0.000132	0.00559	CbGpPWpGaD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—NCOA1—breast cancer	0.000126	0.00535	CbGpPWpGaD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—breast cancer	0.000124	0.00527	CbGpPWpGaD
Carisoprodol—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—breast cancer	0.000123	0.00524	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—GSTA4—breast cancer	0.000122	0.00518	CbGpPWpGaD
Carisoprodol—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—breast cancer	0.000122	0.00517	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—GSTA4—breast cancer	0.00012	0.00511	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—GSTA2—breast cancer	0.000119	0.00505	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—SULT1A1—breast cancer	0.000117	0.00499	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—GPX2—breast cancer	0.000117	0.00498	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—SULT1A1—breast cancer	0.000116	0.00492	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—GPX4—breast cancer	0.000116	0.00492	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—GSTA1—breast cancer	0.000115	0.00487	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—NAT2—breast cancer	0.000113	0.00482	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—NAT2—breast cancer	0.000112	0.00475	CbGpPWpGaD
Carisoprodol—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—breast cancer	0.0001	0.00425	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—SYNJ2—breast cancer	9.6e-05	0.00408	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—MTR—breast cancer	9.25e-05	0.00393	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—HPGDS—breast cancer	9.07e-05	0.00385	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—GSTT1—breast cancer	8.8e-05	0.00374	CbGpPWpGaD
Carisoprodol—CYP2C19—Arachidonic acid metabolism—PTGS2—breast cancer	8.49e-05	0.00361	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—CYP17A1—breast cancer	8.33e-05	0.00354	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—PTGS1—breast cancer	8.24e-05	0.0035	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—CYP17A1—breast cancer	8.21e-05	0.00349	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—CYP2D6—breast cancer	8.08e-05	0.00343	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—CYP2D6—breast cancer	7.97e-05	0.00339	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—NCOA2—breast cancer	7.93e-05	0.00337	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—CYP3A4—breast cancer	7.13e-05	0.00303	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—CYP3A4—breast cancer	7.03e-05	0.00299	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—CYP1B1—breast cancer	7.01e-05	0.00298	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—SLCO1B1—breast cancer	7e-05	0.00297	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—CYP1B1—breast cancer	6.91e-05	0.00294	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—NCOA1—breast cancer	6.69e-05	0.00284	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—CYP19A1—breast cancer	6.59e-05	0.0028	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—CYP19A1—breast cancer	6.5e-05	0.00276	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—ANGPTL4—breast cancer	6.36e-05	0.0027	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—ESRRA—breast cancer	6.36e-05	0.0027	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—COMT—breast cancer	6.13e-05	0.0026	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—GSTP1—breast cancer	6.1e-05	0.00259	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—COMT—breast cancer	6.04e-05	0.00257	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—HADHB—breast cancer	6.03e-05	0.00256	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—GSTP1—breast cancer	6.01e-05	0.00256	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—GSTM1—breast cancer	5.6e-05	0.00238	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—GSTM1—breast cancer	5.53e-05	0.00235	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—FHL2—breast cancer	5.51e-05	0.00234	CbGpPWpGaD
Carisoprodol—CYP2C19—Biological oxidations—CYP1A1—breast cancer	5.31e-05	0.00226	CbGpPWpGaD
Carisoprodol—CYP2C19—Metapathway biotransformation—CYP1A1—breast cancer	5.24e-05	0.00223	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—ABCC1—breast cancer	5.12e-05	0.00218	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—PPARGC1B—breast cancer	4.96e-05	0.00211	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—GPX2—breast cancer	4.57e-05	0.00194	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—GPX4—breast cancer	4.51e-05	0.00192	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—breast cancer	4.41e-05	0.00187	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—SYNJ2—breast cancer	4.27e-05	0.00182	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—NDUFS3—breast cancer	3.97e-05	0.00169	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—MED12—breast cancer	3.82e-05	0.00162	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CHST9—breast cancer	3.74e-05	0.00159	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—NCOA3—breast cancer	3.65e-05	0.00155	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—CPT1A—breast cancer	3.55e-05	0.00151	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—COX11—breast cancer	3.54e-05	0.0015	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—breast cancer	3.48e-05	0.00148	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—ACHE—breast cancer	3.38e-05	0.00144	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CDA—breast cancer	3.24e-05	0.00138	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—SHMT1—breast cancer	3.24e-05	0.00138	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—breast cancer	3.2e-05	0.00136	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—breast cancer	3.17e-05	0.00134	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—SLC2A5—breast cancer	3.12e-05	0.00132	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—SLCO1B1—breast cancer	3.12e-05	0.00132	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—NCOA2—breast cancer	3.05e-05	0.00129	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—APRT—breast cancer	3.01e-05	0.00128	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—FASN—breast cancer	2.96e-05	0.00126	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—breast cancer	2.94e-05	0.00125	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ESRRA—breast cancer	2.83e-05	0.0012	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ANGPTL4—breast cancer	2.83e-05	0.0012	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—breast cancer	2.69e-05	0.00114	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GPI—breast cancer	2.68e-05	0.00114	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—HADHB—breast cancer	2.68e-05	0.00114	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—NCOA1—breast cancer	2.57e-05	0.00109	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ALDH7A1—breast cancer	2.56e-05	0.00109	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ALDH1A1—breast cancer	2.56e-05	0.00109	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—breast cancer	2.53e-05	0.00108	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—FHL2—breast cancer	2.45e-05	0.00104	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—NME1—breast cancer	2.45e-05	0.00104	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ADSL—breast cancer	2.45e-05	0.00104	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PHGDH—breast cancer	2.45e-05	0.00104	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—UMPS—breast cancer	2.45e-05	0.00104	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—HPSE—breast cancer	2.41e-05	0.00102	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—LDHB—breast cancer	2.41e-05	0.00102	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—BRIP1—breast cancer	2.41e-05	0.00102	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—HMMR—breast cancer	2.28e-05	0.000969	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ABCC1—breast cancer	2.28e-05	0.000969	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GSTA3—breast cancer	2.28e-05	0.000969	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PPARGC1B—breast cancer	2.21e-05	0.000939	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	2.15e-05	0.000914	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	2.15e-05	0.000914	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GSTA4—breast cancer	2.09e-05	0.000887	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CA9—breast cancer	2.09e-05	0.000887	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—breast cancer	2.06e-05	0.000875	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	2.04e-05	0.000867	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GSTA2—breast cancer	2.03e-05	0.000864	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GPX2—breast cancer	2.03e-05	0.000864	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—SULT1A1—breast cancer	2.01e-05	0.000854	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GPX4—breast cancer	2.01e-05	0.000854	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GSTA1—breast cancer	1.96e-05	0.000834	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—IDH1—breast cancer	1.96e-05	0.000834	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—NAT2—breast cancer	1.94e-05	0.000824	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.75e-05	0.000745	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—DPYD—breast cancer	1.7e-05	0.000723	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—MED12—breast cancer	1.7e-05	0.000723	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ALDOA—breast cancer	1.67e-05	0.000712	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—NCOA3—breast cancer	1.63e-05	0.000691	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—SLC2A2—breast cancer	1.61e-05	0.000686	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.6e-05	0.000679	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CPT1A—breast cancer	1.58e-05	0.000672	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ABCG2—breast cancer	1.58e-05	0.000672	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—MTR—breast cancer	1.58e-05	0.000672	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—HPGDS—breast cancer	1.55e-05	0.000659	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—HBA1—breast cancer	1.54e-05	0.000655	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GSTT1—breast cancer	1.5e-05	0.000639	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ACHE—breast cancer	1.5e-05	0.000639	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CYP17A1—breast cancer	1.42e-05	0.000605	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PTGS1—breast cancer	1.41e-05	0.000599	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ENO1—breast cancer	1.41e-05	0.000599	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.4e-05	0.000597	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.39e-05	0.000589	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CYP2D6—breast cancer	1.38e-05	0.000587	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—NCOA2—breast cancer	1.36e-05	0.000577	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—FASN—breast cancer	1.32e-05	0.000559	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—BCHE—breast cancer	1.31e-05	0.000557	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—SLC5A5—breast cancer	1.29e-05	0.00055	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—SLC2A1—breast cancer	1.25e-05	0.000531	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—NQO1—breast cancer	1.25e-05	0.000531	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.22e-05	0.00052	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CYP3A4—breast cancer	1.22e-05	0.000518	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.21e-05	0.000515	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CYP1B1—breast cancer	1.2e-05	0.000509	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—HSP90AA1—breast cancer	1.18e-05	0.000499	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—NCOA1—breast cancer	1.14e-05	0.000486	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—STK11—breast cancer	1.13e-05	0.000479	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CYP19A1—breast cancer	1.13e-05	0.000479	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.06e-05	0.000449	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—COMT—breast cancer	1.05e-05	0.000445	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GSTP1—breast cancer	1.04e-05	0.000443	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—HMOX1—breast cancer	1.03e-05	0.000437	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ITPR1—breast cancer	1.03e-05	0.000436	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ABCB1—breast cancer	9.87e-06	0.000419	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—TYMS—breast cancer	9.69e-06	0.000412	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—NCOR1—breast cancer	9.58e-06	0.000407	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PLA2G4A—breast cancer	9.58e-06	0.000407	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GSTM1—breast cancer	9.58e-06	0.000407	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—GPX1—breast cancer	9.18e-06	0.00039	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CYP1A1—breast cancer	9.08e-06	0.000386	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ERCC2—breast cancer	9.01e-06	0.000383	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—MTHFR—breast cancer	8.47e-06	0.00036	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—CAV1—breast cancer	7.81e-06	0.000332	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	7.46e-06	0.000317	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PIK3CG—breast cancer	7.12e-06	0.000302	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PIK3CD—breast cancer	6.25e-06	0.000266	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—ALB—breast cancer	6.17e-06	0.000262	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—NOS3—breast cancer	5.91e-06	0.000251	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PIK3CB—breast cancer	5.45e-06	0.000232	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PTGS2—breast cancer	5.4e-06	0.00023	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PTEN—breast cancer	4.71e-06	0.0002	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—PIK3CA—breast cancer	3.32e-06	0.000141	CbGpPWpGaD
Carisoprodol—CYP2C19—Metabolism—AKT1—breast cancer	2.72e-06	0.000115	CbGpPWpGaD
